TickerFacts.

Outlook Therapeutics, Inc. (OTLK): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2019-09-30, while the company's latest annual report covers the year ended 2025-09-30. Its later filings do not report this line under the concept TickerFacts maps.

$437.3K
Year ended 2019-09-30
-26.4%
3-year compound annual growth
$8.80M2015-09-30: $8.80M2016-09-30: $1.10M2017-09-30: $292.1K2018-09-30: $2.78M2019-09-30: $437.3K$437.3K
2015-09-30 Capital Expenditures (USD) 2019-09-30
Period endedCapital ExpendituresChange YoYSource filing
2019-09-30$437.3K-84.3%2020-12-23, From 2018-10-01
2018-09-30$2.78M+852.2%2019-12-19, From 2017-10-01
2017-09-30$292.1K-73.4%2018-12-18, From 2016-10-01
2016-09-30$1.10M-87.5%2017-12-29, From 2015-10-01
2015-09-30$8.80Mn/a2016-12-29, From 2014-10-01